Cost-effectiveness of nonsteroidal antiinflammatory drug strategies: comment on the article by Spiegel et al.
Loyd
Michael
M
Jacobs
Philip
P
Rublee
Dale
D
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced; D012307:Risk Factors
D000893:Anti-Inflammatory Agents